Ca2+ 释放激活 Ca2+ (CRAC) 通道是一种高度 Ca2+ 选择性钙池操纵通道,在 T 细胞、肥大细胞和各种其他组织中表达。CRAC 通道调节关键的细胞过程,例如基因表达、运动和炎症介质的分泌。Orai1(CRAC 通道孔的关键亚基)和 STIM1(内质网 (ER) Ca2+ 传感器)的识别为阐明 CRAC 通道的调节机制和孔特性提供了工具。
STIM1 蛋白跨越 ER 膜,能够感知腔内 Ca 2+ 浓度,进而负责将 Ca2+ 库耗尽的信号传递到质膜中的成孔 Orai1 蛋白。STIM1 和 Orai1 的直接相互作用允许 Ca2+ 从细胞外空间重新进入。CRAC 通道对淋巴细胞功能和免疫反应至关重要。寻找 CRAC 通道药物的驱动力是人类和小鼠在 STIM1 或 Orai1 中发生无效或功能丧失突变时表现出的免疫功能低下表型,这表明 CRAC 通道抑制剂可成为治疗自身免疫或炎症疾病的有效方法。
The Ca2+ release-activated Ca2+ (CRAC) channel is a highly Ca2+-selective store-operated channel expressed in T cells, mast cells, and various other tissues. CRAC channels regulate critical cellular processes such as gene expression, motility, and the secretion of inflammatory mediators. The identification of Orai1, a key subunit of the CRAC channel pore, and STIM1, the endoplasmic reticulum (ER) Ca2+ sensor, have provided the tools to illuminate the mechanisms of regulation and the pore properties of CRAC channels.
STIM1 proteins span through the membrane of the ER, are competent in sensing luminal Ca 2+ concentration, and in turn, are responsible for relaying the signal of Ca2+ store-depletion to pore-forming Orai1 proteins in the plasma membrane. A direct interaction of STIM1 and Orai1 allows for the re-entry of Ca2+ from the extracellular space. CRAC channels are critical for lymphocyte function and immune responses. A driving force in the quest for CRAC channel drugs has been the immunocompromised phenotype displayed by humans and mice with null or loss-of-function mutations in STIM1 or Orai1, suggesting that CRAC channel inhibitors could be useful therapeutics for autoimmune or inflammatory conditions.
2-Aminoethyl diphenylborinate (2-APB) 是一种细胞通透性 Inositol triphosphate receptor (IP3R) 抑制剂,可抑制 store-operated Ca2+ (SOC) 通道并激活部分 TRP 通道 (V1、V2 和 V3),同时对血管痉挛具有抑制作用,而高浓度的 2-Aminoethyl diphenylborinate 在神经组织中则具有特异性的抗炎和抗氧化效果。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号